Clinical Trial Update: Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update exploring vorinostat with temozolomide for malignant gliomas in adults, with active-not-recruiting status across multiple glioma s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Brain Neoplasm
• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma
• Mixed Glioma

Drugs mentioned

• Temozolomide (Temozolomide)
• Vorinostat (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 | Status: ACTIVE_NOT_RECRUITING